Epigral Ltd

Epigral, a key player in the Specialty Chemicals sector, recorded a fresh 52-week low today at Rs.1376.9, reflecting a notable decline in its stock price amid broader market dynamics and company-specific performance factors.

Epigral, a small-cap player in the Specialty Chemicals sector, has undergone a revision in its market assessment reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued profitability, rising interest expenses, and a bearish technical stance, all contributing to a cautious market perspective on the stock’s near-term prospects.

Epigral, a key player in the specialty chemicals sector, has reached a new 52-week low of Rs.1388.6, marking a significant milestone in its recent price movement. The stock has been on a declining trajectory over the past three days, reflecting a cumulative return of -3.06% during this period.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1388.6, marking a significant milestone in its recent price trajectory. The stock has experienced a sustained decline over the past three trading sessions, reflecting ongoing pressures within the company’s financial performance and market positioning.

Epigral, a small-cap player in the specialty chemicals sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical performance. Recent assessment changes highlight concerns across multiple analytical parameters, signalling a cautious outlook for investors.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, reflecting a significant decline in its stock price over the past year. This development comes amid a backdrop of subdued financial performance and market conditions that have weighed on the company’s valuation.

Epigral, a player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, marking a significant price level for the stock. This development comes amid a backdrop of varied financial indicators and market conditions that have influenced the stock's performance over the past year.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, reflecting a significant decline in its stock price over the past year. This development comes amid a backdrop of subdued financial performance and market dynamics that have weighed on the company’s valuation.

Epigral, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.1400 today, marking a significant point in its recent market performance. This decline comes amid a broader context of subdued returns and financial metrics that reflect ongoing pressures on the company’s growth trajectory.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, marking a significant milestone in its recent trading history. This decline reflects ongoing challenges in the company’s financial performance and market positioning, despite a broader market environment showing resilience.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, reflecting a continuation of subdued market performance amid challenging financial indicators and sector dynamics.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1428, marking a significant decline in its stock price amid broader market movements and sector-specific pressures.

Epigral, a key player in the Specialty Chemicals sector, has reached a fresh 52-week low of Rs.1428, marking a significant price level as the stock continues to trade below all major moving averages amid broader market gains.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1428 today, marking a significant price level as the stock continues to trade below all major moving averages amid broader market gains.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1428, marking a significant decline in its stock price amid broader market movements and sector-specific pressures.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1428, marking a significant price level as the stock underperforms both its sector and broader market indices.

Epigral, a key player in the Specialty Chemicals sector, has reached a fresh 52-week low of Rs.1428, marking a significant decline in its stock price amid broader market movements and sector-specific pressures.

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1428, reflecting a notable decline in its stock price amid broader market dynamics and company-specific performance factors.